RxDoctor Payments Data

Daniel Schmitt

Orthopaedic Surgery · Maywood, ILNPI 1407240062

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $118,803 of the $125,329 with a category attached, or 94.8%. Surgical Planning Associates, Inc. accounts for 94.8% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $60,233, more than ten times the $942 reported in 2019. Among orthopaedic surgery clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$125,329in general payments, 2019–2025

Across 80 payments — averaging $1566.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Surgical Planning Associates, Inc.$119K
  • Stryker$3K
  • Zimmer Biomet$816
  • Johnson & Johnson$759
  • Medical Device Business Services, Inc.$756
  • Microport Orthopedics Inc$687
  • plus $824 from 4 others

What the payments were for

  • Consulting fees$118,80395%
  • Travel & lodging$8511%
  • Food & beverage$4,9884%
  • Education$6871%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$125,329 in reported general payments places this provider in the 90th percentile of 844 orthopaedic surgery providers in Illinois.

See all orthopaedic surgery providers in Illinois →

Medicare billing

Part B allowed, 2024
$150,084
Medicare patients
302
Services billed
1,247

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam23$48

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Maywood

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →